Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma

Abstract Background Aidi Injection (ADI), a Chinese herbal preparation with anti-cancer activity, is used for the treatment of hepatocellular carcinoma (HCC). Several clinical studies have shown that co-administration of ADI with doxorubicin (DOX) is associated with reduced toxicity of chemotherapy,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuan Lu, Jie Pan, Xiaoqing Zhu, Shuai Zhang, Chunhua Liu, Jia Sun, Yueting Li, Siying Chen, Jing Huang, Chuang Cao, Yonglin Wang, Yongjun Li, Ting Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-09-01
coleção:	BMC Pharmacology and Toxicology
Assuntos:	Pharmacokinetic herb-drug interaction Hepatocellular carcinoma Aidi injection Doxorubicin Doxorubicinol Rat
Acesso em linha:	https://doi.org/10.1186/s40360-021-00515-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!